News & Alerts
-
Oct- 2023 -24 October
Hamilton Field Services Forge Expert Partnerships in Pharma and Life Sciences Industries
RENO, Nev., Oct. 24, 2023 – Hamilton, the globally recognized leader in automation technology and analytical sensors, has unveiled a…
Read More » -
24 October
Study Reveals 72% of Consumers Concerned About Health Data Misuse, as Lack of Informed Consent Tops Data Privacy Worries
WARRINGTON, England, Oct. 24, 2023. A recent research report released by Cassie, a globally recognized consent management platform serving Fortune…
Read More » -
23 October
Innovative Anti-Tumor Drug, LX-039, Shows Promise in Phase I Clinical Study Data Presented at ESMO 2023
SHANGHAI, Oct. 23, 2023 — Luoxin Pharmaceutical Group Stock Co., Ltd. (Luoxin Pharmaceutical) has made a significant stride in the…
Read More » -
23 October
Sumitomo Pharma’s ORGOVYX Receives Health Canada Approval for Advanced Prostate Cancer Treatment
MISSISSAUGA, Ontario, Oct. 23, 202— In a significant development in the field of advanced prostate cancer treatment, Sumitomo Pharma Canada,…
Read More » -
23 October
INVO Bioscience and NAYA Biosciences Announce Merger for Breakthrough Fertility and Oncology Treatments
SARASOTA, Fla. and AVENTURA, Fla., Oct. 23, 2023 — INVO Bioscience, Inc. (Nasdaq: INVO) and NAYA Biosciences Inc. have jointly…
Read More » -
19 October
Commonly Used Drug Amitriptyline Might Be New Treatment Option for IBS
By Cara Murez HealthDay Reporter An inexpensive medication long used for depression and migraines now has a clinical trial to…
Read More » -
19 October
FDA Grants Approval to UCB’s Bimzelx (bimekizumab-bkzx) for Moderate to Severe Plaque Psoriasis Treatment
UCB, a global biopharmaceutical company, has announced the approval of Bimzelx® (bimekizumab-bkzx) by the U.S. Food and Drug Administration (FDA)…
Read More » -
19 October
Sterile Dosage Form Market Anticipated to Reach US$ 1.1 Billion by 2033, Driven by Rising Demand for Infection-Free Medical Products | Future Market Insights, Inc.
The sterile dosage forms market will be valued at US$ 582.9 million in 2023. The market is anticipated to grow at a 6.7% CAGR throughout the…
Read More » -
19 October
Cholangiocarcinoma Market Growth Projection 2019 to 2032 By DelveInsight
DelveInsight, a leading market intelligence and analytics firm, has unveiled its comprehensive report on the Cholangiocarcinoma market. This report provides…
Read More » -
19 October
Doxorubicin Market Expected to Grow by USD 469.97 Million from 2022 to 2027, with North America Leading the Way – Technavio
The doxorubicin market is poised for substantial expansion over the coming years, with a projected increase of USD 469.97 million…
Read More »